Price of life i.e. costs of treatment of neoplastic diseases of blood

Wiesław Wiktor Jędrzejczak

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

5/2000
vol. 4

Send email

Copy url:

abstract:

Price of life i.e. costs of treatment of neoplastic diseases of blood

Wiesław Wiktor Jędrzejczak

Współcz Onkol (2000) vol. 4, 5 (207-211)

Online publish date: 2003/07/30

View full text Get citation

Essential goals of therapy of neoplastic blood disorders, principles of cost analysis including three major disease related groups such as: acute leukemias and myelodysplastic syndromes, lymphomas, and chronic myeloproliferative disorders were reviewed. Subsequently, the results of cost analysis were shown divided into main phases of therapy and main components. They were analyzed in context of reimbursement quotas imposed by the Mazovian Regional Health Insurance Authority. Furthermore, these results were discussed in the context of published costs of similar procedures in the U.S., as well as in the context of prices of non-medical products in Poland and in the U.S. In general, identical medical procedures (utilizing the same drugs and manouvers) cost many times less in Poland while the non-medical prices (food and industrial products) are similar.

keywords:

Price of life i.e. costs of treatment of neoplastic diseases of blood

Wiesław Wiktor Jędrzejczak

cost-effectiveness, leukemia, lymphoma, methodology of medical costs analysis